US$ 21.78
glp-1 obesity drug news today oct 23 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ GLP-1 Agonists Weight Loss Drugs
Description
GLP-1 agonists have demonstrated safety and efficacy in clinical trials for weight loss, but individual safety depends on medical history, dosing protocol, and ongoing provider oversight

CivicScience offers insights into the impact of cost, side effects & trends in GLP-1 usage.

The once-daily pill offers new oral cardiovascular risk-reduction option for plan members with diabetes

Learn their history, when they were introduced, and why these medications are widely used today.

ICD-10 codes to identify the outcome are included in supplementary table S1
Could it be because Indian physicians are conservative when it comes to prescribing newer drugs